Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Prospective, Randomized, Placebo-Controlled, Delayed Treatment, Double-Blind Study to Evaluate the Effectiveness and Safety of a Single Oral Dose of Solosec® for the Treatment of Trichomoniasis

NCT03935217 is registered in ClinicalTrials.gov with Lupin Research Inc as lead sponsor.

NCT NCT03935217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03935217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Prospective, Randomized, Placebo-Controlled, Delayed Treatment, Double-Blind Study to Evaluate the Effectiveness and Safety of a Single Oral Dose of Solosec® for the Treatment of Trichomoniasis
Lead sponsor
Lupin Research Inc
Phase
Phase 3
Overall status
Completed
Start date
April 23, 2019
Completion date
March 25, 2020
Enrollment
147 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

trichomonas infection